Skip to main content
Log in

Cost sharing decreases adherence to ACS medication

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. β-adrenergic receptor antagonists

  2. HMG-CoA reductase inhibitors

Reference

  • Gonzalez Lopez-Valcarcel B, et al. Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome. Heart : Mar 2017. Available from: URL: http://doi.org/10.1136/heartjnl-2016-310610

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cost sharing decreases adherence to ACS medication. PharmacoEcon Outcomes News 774, 11 (2017). https://doi.org/10.1007/s40274-017-3835-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3835-9

Navigation